Switch to:
More From Other Websites
7 Companies That Destroyed Shareholders Last Week Dec 10 2016
Repros Therapeutics Drops on FDA Vote Dec 07 2016
REPROS THERAPEUTICS INC. Files SEC form 8-K, Regulation FD Disclosure Dec 07 2016
FDA Advisory Committee Discusses Clinical Trial Designs for Obesity-Related Hypogonadism Dec 06 2016
10 Major Pharma and FDA Catalysts Coming in December Dec 05 2016
REPROS THERAPEUTICS INC. Financials Nov 17 2016
Repros Therapeutics upgraded by Ladenburg Thalmann Nov 16 2016
REPROS THERAPEUTICS INC. Files SEC form 8-K, Regulation FD Disclosure Nov 15 2016
Repros (RPRX) Reports Positive Top-Line Data on Proellex Nov 15 2016
REPROS THERAPEUTICS INC. Files SEC form 8-K, Regulation FD Disclosure Nov 14 2016
Repros Reports Topline Positive Clinical Data After Two 18 Week Courses of Proellex® Delivered... Nov 14 2016
Repros (RPRX) Loss Narrower Y/Y in Q3, Pipeline in Focus Nov 09 2016
REPROS THERAPEUTICS INC. Files SEC form 10-Q, Quarterly Report Nov 09 2016
Repros Therapeutics Inc.® Reports Third Quarter 2016 Financial Results Nov 08 2016
Repros Therapeutics reports 3Q loss Nov 08 2016
Repros Therapeutics reports 3Q loss Nov 08 2016
Repros Therapeutics reports 3Q loss Nov 08 2016
REPROS THERAPEUTICS INC. Files SEC form 8-K, Results of Operations and Financial Condition Nov 08 2016
Repros Therapeutics Inc.® Reports Third Quarter 2016 Financial Results Nov 08 2016
What to Expect from Repros (RPRX) This Earnings Season Nov 03 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK